Oncolytics Biotech
ONCY
#9263
Rank
โ‚ฌ86.14 M
Marketcap
0,81ย โ‚ฌ
Share price
-4.78%
Change (1 day)
-2.56%
Change (1 year)

Oncolytics Biotech (ONCY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ9.21 Million

According to Oncolytics Biotech 's latest financial reports the company's total liabilities are โ‚ฌ9.21 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oncolytics Biotech - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ9.51 M23.89%
2023-12-31โ‚ฌ7.67 M3.17%
2022-12-31โ‚ฌ7.44 M9.81%
2021-12-31โ‚ฌ6.77 M10.8%
2020-12-31โ‚ฌ6.11 M-54.73%
2019-12-31โ‚ฌ13.5 M142.83%
2018-12-31โ‚ฌ5.56 M-14.94%
2017-12-31โ‚ฌ6.54 M127.23%
2016-12-31โ‚ฌ2.87 M61.13%
2015-12-31โ‚ฌ1.78 M-25.27%
2014-12-31โ‚ฌ2.39 M-41.51%
2013-12-31โ‚ฌ4.08 M-26.26%
2012-12-31โ‚ฌ5.54 M12.58%
2011-12-31โ‚ฌ4.92 M161.79%
2010-12-31โ‚ฌ1.88 M-32.92%
2009-12-31โ‚ฌ2.8 M5.12%
2008-12-31โ‚ฌ2.66 M37.72%
2007-12-31โ‚ฌ1.93 M7.56%
2006-12-31โ‚ฌ1.8 M34.79%
2005-12-31โ‚ฌ1.33 M98.01%
2004-12-31โ‚ฌ0.67 M6.47%
2003-12-31โ‚ฌ0.63 M-25.81%
2002-12-31โ‚ฌ0.85 M-61.47%
2001-12-31โ‚ฌ2.21 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Aeterna Zentaris
AEZS
โ‚ฌ20.46 M 121.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ78.25 B 848,659.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ67.25 B 729,425.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ28.00 B 303,697.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
โ‚ฌ62.18 M 574.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
โ‚ฌ0.15 B 1,607.52%๐Ÿ‡บ๐Ÿ‡ธ USA